Dr. Aramis Odysseus: Using local and systemic delivery of CRISPR/Cas9 constructs, 3 separate teams show successful gene therapy treatment in the mouse model of Duchenne Muscular Dystrophy offering hope for clinical translation to human patients.

01 January, 2016

Using local and systemic delivery of CRISPR/Cas9 constructs, 3 separate teams show successful gene therapy treatment in the mouse model of Duchenne Muscular Dystrophy offering hope for clinical translation to human patients.

See the source article by following the link below:
Using local and systemic delivery of CRISPR/Cas9 constructs, 3 separate teams show successful gene therapy treatment in the mouse model of Duchenne Muscular Dystrophy offering hope for clinical translation to human patients.

No comments:

Subscribe to: Post Comments (Atom)